Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 496
interventional 378
Observational 110
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 195
Drug|placebo 81
Device 45
Other 15
Behavioral 13
Dietary Supplement 7
Procedure 7
Drug|Procedure 3
Behavioral|Device 2
Device|Other 2
Behavioral|Diagnostic Test 1
Behavioral|Drug|Other 1
Behavioral|Other 1
Biological 1
Biological|Device 1
Device|Drug|Procedure 1
Diagnostic Test 1
Drug|Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 125
NA 43
Japan 18
Canada 7
Germany 7
United States|Canada 7
China 6
France 6
Korea, Republic of 6
Russian Federation 6
United Kingdom 5
Netherlands 4
Australia 3
India 3
Malawi 3
Belgium 2
China|Japan 2
Egypt 2
Ireland|Netherlands|Sweden|United Kingdom 2
Italy 2
Japan|Korea, Republic of 2
Mexico 2
Portugal 2
Spain 2
Switzerland 2
Taiwan 2
United States|Korea, Republic of|Mexico 2
Australia|Austria|Belgium|Canada|Germany|Netherlands|Poland|Portugal|Spain|United Kingdom| 1
Australia|Austria|Belgium|Finland|France|Germany|Italy|Netherlands|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Australia|China|Japan|Korea, Republic of|Malaysia|Taiwan|Thailand 1
Australia|Croatia|Czechia|Finland|France|Germany|Hungary|Lithuania|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
Australia|United States|Argentina|Belgium|Canada|Chile|Czechia|Finland|France|Germany|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
Austria|Bosnia and Herzegovina|Croatia|Czechia|France|Germany|Hungary|Italy|Malaysia|Moldova, Republic of|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Ukraine|United Kingdom 1
Austria|Bulgaria|Croatia|Czechia|France|Germany|Poland|Portugal|Romania|Spain 1
Austria|Canada|France|Germany|Italy|Lithuania|Spain|United Kingdom| 1
Austria|Denmark|France|Germany|Italy|Norway|United Kingdom 1
Bangladesh 1
Belgium|Bulgaria|Colombia|Costa Rica|Czech Republic|France|Germany|Greece|India|Italy|Korea, Republic of|Lithuania|Mexico|Panama|Peru|Philippines|Russian Federation|Spain|Taiwan|Turkey|Venezuela 1
Belgium|Bulgaria|Denmark|France|Germany|Italy|Netherlands|Poland|Russian Federation|Spain|Thailand|Ukraine 1
Belgium|Bulgaria|France|Germany|Italy|Netherlands|Poland|Russian Federation|Thailand|Ukraine 1
Belgium|Czech Republic|Finland|France|Germany|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Czechia|France|Germany|Ireland|Italy|Netherlands|United Kingdom 1
Belgium|Estonia|France|Hungary|Italy|Latvia|Poland|Spain|Ukraine 1
Belgium|Finland|France|Netherlands|Poland|Portugal|Switzerland|United Kingdom| 1
Belgium|Finland|France|Poland|Portugal|Switzerland 1
Belgium|Germany|Netherlands|Norway|United Kingdom 1
Costa Rica|El Salvador|Guatemala|Peru 1
Croatia|Czechia|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|China|Colombia|Estonia|France|Georgia|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Moldova, Republic of|Montenegro|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Taiwan|Thailand|Ukraine|United Kingdom 1
Czech Republic|France|United States|Belgium|Brazil|Canada|Germany|Hungary|India|Italy|Mexico|Poland|Romania|Russian Federation|South Africa|United Kingdom 1
Czech Republic|Spain|United Kingdom 1
Czechia|Bulgaria|Canada|United States|Australia|Belgium|France|Germany|Hungary|Italy|Japan|Lithuania|Mexico|Poland|Portugal|Slovakia|Spain|Turkey|United Kingdom 1
Czechia|Hungary|Italy|Poland|Spain|United Kingdom 1
Denmark 1
Finland 1
Greece 1
India|Australia|Bulgaria|Czech Republic|Estonia|Germany|Hong Kong|Hungary|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Taiwan|Thailand|Ukraine 1
India|Australia|Denmark|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Montenegro|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
India|Belgium|Finland|France|Germany|Hungary|Italy|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
Iran, Islamic Republic of 1
Israel 1
Italy|Netherlands|Poland|Russian Federation|Ukraine 1
Japan|China 1
Japan|Malaysia|Philippines|Singapore|Taiwan|Thailand 1
Korea, Republic of|Malaysia|Thailand 1
Latvia 1
Malawi|Zambia 1
Pakistan 1
Peru 1
Poland 1
Poland|United States|Argentina|Australia|Belgium|Bulgaria|Colombia|Croatia|Czechia|Estonia|Georgia|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Montenegro|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Taiwan|Thailand|Ukraine|United Kingdom 1
Poland|United States|Argentina|Australia|Belgium|Canada|Chile|Germany|Greece|India|Israel|New Zealand|Russian Federation|South Africa|Spain 1
Qatar 1
Romania|Mexico|United States|Austria|Bulgaria|Czechia|Denmark|Finland|France|Greece|Italy|Russian Federation|Spain|Switzerland|Turkey 1
Russian Federation|United States|Mexico|Poland 1
Saudi Arabia 1
South Africa|United States|Austria|Belgium|Finland|France|Germany|India|Israel|Italy|Netherlands|Russian Federation|Sweden|United Kingdom 1
Sweden 1
Uganda 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Chile|China|Czech Republic|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Sweden|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Chile|Finland|France|Hungary|India|Israel|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Poland|Russian Federation|South Africa|Spain|Taiwan|Thailand|Ukraine 1
United States|Argentina|Australia|Belgium|Canada|Chile|Germany|Greece|Hungary|India|Israel|New Zealand|Poland|Russian Federation|South Africa|Spain 1
United States|Argentina|Australia|Belgium|Canada|Colombia|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Bulgaria|Chile|Czechia|Germany|Hungary|Korea, Republic of|Mexico|Poland|Russian Federation|Serbia|Spain|Sweden|Ukraine 1
United States|Argentina|Belgium|Brazil|Canada|Cyprus|France|Germany|Greece|Italy|Poland 1
United States|Argentina|Belgium|Brazil|Canada|Czech Republic|France|Germany|Hungary|Italy|Mexico|Poland|Romania|Russian Federation|United Kingdom 1
United States|Argentina|Bosnia and Herzegovina|Bulgaria|Czechia|Germany|Hong Kong|Hungary|India|Malaysia|Mexico|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Thailand 1
United States|Argentina|Brazil|Bulgaria|China|Croatia|Czechia|France|Georgia|Greece|Hungary|Israel|Italy|Korea, Republic of|Mexico|Moldova, Republic of|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Taiwan|Thailand|Ukraine 1
United States|Argentina|Brazil|Canada|Chile|Mexico 1
United States|Argentina|Brazil|Canada|Mexico 1
United States|Argentina|Brazil|Chile|Germany|India|Korea, Republic of|Malaysia|Puerto Rico|Russian Federation|Ukraine 1
United States|Argentina|Brazil|Chile|Germany|India|Korea, Republic of|Puerto Rico|Russian Federation|Ukraine 1
United States|Argentina|Chile|Peru 1
United States|Australia|Austria|Belgium|Czechia|Germany|Lithuania|Spain 1
United States|Australia|Austria|Belgium|Czechia|Japan|Korea, Republic of 1
United States|Australia|Austria|Canada|Denmark|France|Germany|Ireland|Italy|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belarus|India|Lithuania 1
United States|Australia|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Italy|Japan|Lithuania|Mexico|Poland|Romania|Serbia|Slovakia|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Brazil|Bulgaria|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Romania|Russian Federation|Slovakia|Spain|Taiwan 1
United States|Australia|Belgium|Canada|Colombia|France|Hungary|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia|Belgium|Czech Republic|Estonia|Finland|France|Germany|Latvia|Lithuania|Netherlands|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|France|Germany|Hungary|Israel|Poland|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
United States|Australia|Brazil|Bulgaria|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Romania|Russian Federation|Slovakia|Spain|Taiwan 1
United States|Australia|Brazil|Canada|Mexico 1
United States|Australia|Bulgaria|Czechia|France|Germany|Hungary|Israel|Korea, Republic of|Poland|Romania|Serbia|Spain|Thailand|Ukraine 1
United States|Australia|Bulgaria|Germany|Poland|Russian Federation 1
United States|Australia|Canada|Denmark|Germany|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Jamaica 1
United States|Austria|Belarus|Bosnia and Herzegovina|Bulgaria|China|Croatia|Denmark|France|Greece|Hungary|India|Korea, Republic of|Lebanon|Malaysia|Montenegro|Philippines|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Turkey|Ukraine|United Kingdom 1
United States|Austria|Belgium|Brazil|Bulgaria|Canada|Czechia|Estonia|Finland|France|Germany|Hong Kong|Hungary|India|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|China|Czechia|France|Germany|Greece|Hungary|India|Israel|Italy|Korea, Republic of|Lebanon|Malaysia|Montenegro|Philippines|Poland|Romania|Russian Federation|Serbia|Singapore|Slovakia|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|China|France|Germany|Greece|Hungary|Israel|Korea, Republic of|Lebanon|Malaysia|Philippines|Romania|Russian Federation|Serbia|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Belgium|Bulgaria|Czechia|France|Greece|Hungary|Israel|Italy|Korea, Republic of|Malaysia|Philippines|Poland|Romania|Serbia|Singapore|Turkey|Ukraine 1
United States|Belgium|Canada|Czechia|France|Hungary|Italy|Japan|Korea, Republic of|Latvia|Poland|Spain 1
United States|Belgium|Czechia|Denmark|France|Germany|Spain 1
United States|Belgium|Mexico 1
United States|Brazil|India|Mexico 1
United States|Bulgaria|Canada|Croatia|Mexico|Poland|Romania|Russian Federation 1
United States|Bulgaria|Czechia|Hungary|India|Korea, Republic of|Mexico|Poland|Thailand 1
United States|Bulgaria|Czechia|Hungary|Poland|Slovakia|Ukraine 1
United States|Bulgaria|Germany|Hungary|Italy|Korea, Republic of|Poland|Slovakia|Switzerland|Taiwan 1
United States|Canada|South Africa 1
United States|Czech Republic|Hong Kong|Ukraine 1
United States|Finland 1
United States|France|Hungary|Mexico|Poland 1
United States|France|Spain|United Kingdom 1
United States|Germany|Hungary|Korea, Republic of|Poland|Slovakia 1
United States|Germany|Hungary|Lithuania|Poland|Sweden|Switzerland|United Kingdom 1
United States|India|Korea, Republic of|Poland 1
United States|Italy 1
United States|Mexico|Poland|Russian Federation 1
United States|Netherlands|Poland 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 176
2 20
3 9
4 9
5 6
6 3
7 6
8 6
9 7
10 3
11 4
12 3
13 1
14 4
15 1
16 1
17 2
18 3
19 2
20 1
21 2
22 2
23 1
24 4
25 2
26 2
27 3
28 1
29 2
31 3
32 1
33 1
34 1
36 1
37 2
38 1
40 1
42 1
43 2
44 1
45 1
46 2
47 3
48 1
51 2
53 2
54 2
55 1
56 1
57 2
58 1
59 1
60 1
66 2
67 2
68 3
69 1
70 2
71 1
72 1
73 2
74 1
76 3
77 1
80 1
82 1
84 1
85 1
86 2
87 1
88 2
89 1
91 1
92 2
94 1
97 1
103 1
104 1
106 1
108 1
109 1
115 1
117 1
118 1
119 1
127 1
133 1
137 1
140 1
146 1
148 2
151 1
155 1
158 1
161 1
162 1
207 1
239 1

Phase

Phase Study_Count
Phase 3 138
N/A 95
Phase 2 64
Phase 4 41
Phase 1 17
Phase 1/Phase 2 13
Phase 2/Phase 3 8
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 106
2 139
3 51
4 13
5 5
6 3
NA 61

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 30 5.000 16.00000 6.00000 4.000 1.000 9.0000 9.0000
1st Qu. 114 23.000 22.00000 10.00000 30.000 46.500 98.0000 60.0000
Median 198 47.000 43.00000 18.00000 52.000 93.500 224.0000 106.0000
Mean 198 1297.234 46.88235 48.30769 1682.619 200.625 283.0657 316.3415
3rd Qu. 282 100.000 59.00000 61.00000 142.500 161.750 398.0000 231.0000
Max. 366 100000.000 108.00000 280.00000 100000.000 1000.000 1345.0000 3800.0000

Trial Group Type

group_type Group_Count
Experimental 366
Active Comparator 123
Placebo Comparator 92
NA 61
No Intervention 24
Other 21
Sham Comparator 6

Intervention Model

intervention_model Study_Count
Parallel Assignment 197
Single Group Assignment 140
Crossover Assignment 30
NA 7
Sequential Assignment 3
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 313
Prevention 15
Diagnostic 12
Basic Science 9
Other 9
NA 8
Supportive Care 7
Health Services Research 3
Device Feasibility 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 40
NA 11
France 9
China 5
Germany 5
Switzerland 3
Canada 2
India 2
Israel 2
Japan 2
United Kingdom 2
United States|Canada 2
Australia 1
Austria 1
Austria|Denmark|Germany|Norway|Sweden 1
Belgium 1
Egypt|Germany|India|Sri Lanka 1
Finland 1
France|Czech Republic|Denmark|Germany|Ireland|Norway|Sweden|United Kingdom 1
France|Germany|Netherlands|Spain|United Kingdom 1
Germany|Austria 1
Ireland|Netherlands|Sweden|United Kingdom 1
Korea, Republic of 1
Netherlands 1
Serbia 1
Singapore 1
Spain 1
Taiwan 1
Turkey 1
Ukraine 1
United Kingdom|Denmark|Germany|Hungary|Ireland|Italy|Netherlands|Norway|Spain 1
United States|Canada|Israel|Singapore|United Kingdom 1
United States|Canada|Thailand|United Kingdom 1
United States|Denmark|Iran, Islamic Republic of|Italy 1
United States|France|Russian Federation 1
United States|Peru 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 78
2 9
3 1
4 1
5 3
6 1
7 3
11 1
12 1
15 1
17 1
21 1
25 1
27 1
37 1
41 1
42 1
43 1
52 1
62 1
107 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 75.000
Median 164.000
Mean 2709.294
3rd Qu 500.000
Max 211672.000

Observation Model

observational_model Study_Count
Cohort 64
NA 20
Case-Only 11
Case-Control 7
Family-Based 3
Case Control 2
Other 2
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 75
Retrospective 18
NA 11
Cross-Sectional 3
Other 2
Cross-Sectional, Retrospective 1

Registries

Studies by Country

Country Study_Count
United States 3
Belgium 1
Denmark 1
France|United Kingdom 1
NA 1
United States|Australia|Austria|Belgium|Canada|China|India|Israel|Italy|Japan|Netherlands|Poland|Portugal|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 5
4 1
9 1
57 1

Enrollment Metrics

Measure Registries
Min 30.00
1st Qu 115.75
Median 253.50
Mean 507.25
3rd Qu 475.00
Max 2000.00

Registry Model

observational_model Study_Count
Cohort 6
Case-Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 5
Cross-Sectional 2
Other 1

Follow-up

target_duration Study_Count
5 Years 2
1 Month 1
1 Week 1
2 Years 1
20 Years 1
3 Years 1
4 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03895658 Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) https://ClinicalTrials.gov/show/NCT03895658 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT03406702 A Phase 2 Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures https://ClinicalTrials.gov/show/NCT03406702 Completed Jazz Pharmaceuticals 2019-03-29
NCT03373383 Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy https://ClinicalTrials.gov/show/NCT03373383 Completed UCB Pharma 2019-12-18
NCT03370120 Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy https://ClinicalTrials.gov/show/NCT03370120 Enrolling by invitation UCB Pharma 2022-07-31
NCT03369093 RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia https://ClinicalTrials.gov/show/NCT03369093 Recruiting International Centre for Diarrhoeal Disease Research, Bangladesh 2020-08-31
NCT03826056 Neurology Inpatient Clinical Education Trial https://ClinicalTrials.gov/show/NCT03826056 Active, not recruiting Dartmouth-Hitchcock Medical Center 2020-10-31
NCT03361826 Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder https://ClinicalTrials.gov/show/NCT03361826 Recruiting Centre for Addiction and Mental Health 2020-12-31
NCT03360656 Transnasal Induction of Normothermia in Febrile Stroke Patients https://ClinicalTrials.gov/show/NCT03360656 Recruiting CoolTech LLC 2020-07-31
NCT03355300 Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures https://ClinicalTrials.gov/show/NCT03355300 Recruiting INSYS Therapeutics Inc 2019-11-30
NCT03340064 A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age https://ClinicalTrials.gov/show/NCT03340064 Recruiting UCB Pharma 2023-08-31
NCT03336242 Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures https://ClinicalTrials.gov/show/NCT03336242 Recruiting INSYS Therapeutics Inc 2019-06-30
NCT03329703 Project UPLIFT for Psychogenic Non-Epileptic Seizures https://ClinicalTrials.gov/show/NCT03329703 Recruiting Dartmouth-Hitchcock Medical Center 2020-07-31
NCT03313362 Detecting PNES With Single-channel sEMG https://ClinicalTrials.gov/show/NCT03313362 Active, not recruiting Brain Sentinel 2019-06-21
NCT03299842 A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome https://ClinicalTrials.gov/show/NCT03299842 Enrolling by invitation Zogenix, Inc. 2020-01-01
NCT03288129 Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures https://ClinicalTrials.gov/show/NCT03288129 Active, not recruiting Eisai Inc. 2021-04-27
NCT03283371 Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy https://ClinicalTrials.gov/show/NCT03283371 Active, not recruiting Biogen 2020-01-10
NCT03250377 A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization https://ClinicalTrials.gov/show/NCT03250377 Enrolling by invitation UCB Pharma 2025-02-28
NCT03233399 Modulating Movement Intention Via Cortical Stimulation https://ClinicalTrials.gov/show/NCT03233399 Recruiting NYU Langone Health 2020-04-30
NCT03228264 A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia. https://ClinicalTrials.gov/show/NCT03228264 Recruiting University of Bern 2021-11-30
NCT03209323 Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol https://ClinicalTrials.gov/show/NCT03209323 Completed Medical University of Silesia 2008-12-13
NCT03207685 Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System https://ClinicalTrials.gov/show/NCT03207685 Recruiting Empatica, Inc. 2019-06-26
NCT03206502 Embrace: Seizure Characterization https://ClinicalTrials.gov/show/NCT03206502 Enrolling by invitation Empatica, Inc. 2026-05-31
NCT03201900 Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Patients With Partial Onset Seizures (Including Secondarily Generalized Seizures) (FREEDOM Study) https://ClinicalTrials.gov/show/NCT03201900 Active, not recruiting Eisai Inc. 2019-02-28
NCT03198949 A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II) https://ClinicalTrials.gov/show/NCT03198949 Recruiting Yonsei University 2020-04-30
NCT03198494 Acoustic Stimulation for Seizure Suppression https://ClinicalTrials.gov/show/NCT03198494 Enrolling by invitation NYU Langone Health 2021-08-17
NCT03191058 Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression https://ClinicalTrials.gov/show/NCT03191058 Active, not recruiting University of Texas Southwestern Medical Center 2022-07-31
NCT03181945 Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome https://ClinicalTrials.gov/show/NCT03181945 Active, not recruiting Postgraduate Institute of Medical Education and Research 2018-09-30
NCT03168542 Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2 https://ClinicalTrials.gov/show/NCT03168542 Completed Johnson & Johnson Vision Care, Inc. 2017-05-04
NCT03165981 Fever After Simultaneous Versus Sequential Vaccination in Young Children https://ClinicalTrials.gov/show/NCT03165981 Completed Duke University 2018-01-15
NCT03160664 Magnetic Seizure Therapy for Bipolar Mania https://ClinicalTrials.gov/show/NCT03160664 Recruiting Shanghai Mental Health Center 2021-03-31
NCT03154307 Repeated TMS at Low Frequencies to Reduce Seizure Occurrence https://ClinicalTrials.gov/show/NCT03154307 Recruiting Baptist Health South Florida 2023-12-31
NCT03150485 Clinical Evaluation of Fitting Investigational Contact Lenses https://ClinicalTrials.gov/show/NCT03150485 Completed Johnson & Johnson Vision Care, Inc. 2017-03-31
NCT03138876 EEG Cap for Identification of Non-Convulsive Status Epilepticus https://ClinicalTrials.gov/show/NCT03138876 Completed Mayo Clinic 2018-08-16
NCT03126682 Effect of Bupropion on Seizure Threshold in Depressed Patients https://ClinicalTrials.gov/show/NCT03126682 Completed Duke University 2018-05-31
NCT03116828 A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures https://ClinicalTrials.gov/show/NCT03116828 Completed Sunovion 2019-06-06
NCT03098745 Fitting Evaluation of Hydrogel and Silicone Hydrogel Sphere Design Contact Lenses https://ClinicalTrials.gov/show/NCT03098745 Completed Coopervision, Inc. 2017-03-01
NCT03083665 A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy https://ClinicalTrials.gov/show/NCT03083665 Recruiting UCB Pharma 2022-07-31
NCT03071783 Intra-operative Feed Back on Traction Force During Vacuum Extraction: Safe Vacuum Extraction Alliance https://ClinicalTrials.gov/show/NCT03071783 Completed Karolinska Institutet 2018-06-15
NCT03048084 Seizure Treatment in Glioma https://ClinicalTrials.gov/show/NCT03048084 Recruiting Leiden University Medical Center 2021-02-01
NCT03021018 A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting https://ClinicalTrials.gov/show/NCT03021018 Completed UCB Pharma 2018-04-27
NCT03003156 50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia https://ClinicalTrials.gov/show/NCT03003156 Completed Shanghai Mental Health Center 2017-02-28
NCT02976545 Emotional Lived in Patients Suffering From Psychogenic Nonepileptic Seizures : Study by Functional Magnetic Resonance Imaging https://ClinicalTrials.gov/show/NCT02976545 Recruiting Central Hospital, Nancy, France 2021-10-31
NCT02962414 Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment https://ClinicalTrials.gov/show/NCT02962414 Active, not recruiting Novartis 2027-08-04
NCT02960347 Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures https://ClinicalTrials.gov/show/NCT02960347 Completed Herzog Hospital 2016-05-31
NCT02929667 Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI https://ClinicalTrials.gov/show/NCT02929667 Completed University of Iowa 2019-03-06
NCT02928159 Low Pulse Amplitude Seizure Therapy (LAP-ST Study) https://ClinicalTrials.gov/show/NCT02928159 Completed Behman Hospital 2015-06-30
NCT02899611 A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures https://ClinicalTrials.gov/show/NCT02899611 Active, not recruiting Cerebral Therapeutics LLC 2021-02-28
NCT02897856 Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures https://ClinicalTrials.gov/show/NCT02897856 Completed Hamad Medical Corporation 2018-11-30
NCT02881957 Hypovitaminosis D in Neurocritical Patients https://ClinicalTrials.gov/show/NCT02881957 Completed University of Utah 2018-10-10
NCT02850913 Doxycycline for the Treatment of Nodding Syndrome https://ClinicalTrials.gov/show/NCT02850913 Recruiting Makerere University 2020-04-05
NCT02834793 Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome https://ClinicalTrials.gov/show/NCT02834793 Recruiting Eisai Inc. 2022-01-28
NCT02801136 Treatment Outcomes of CBT for PNES https://ClinicalTrials.gov/show/NCT02801136 Recruiting University of Alabama at Birmingham 2020-06-30
NCT02796924 Treating Non-epileptic Seizures Using Magnetic Brain Stimulation https://ClinicalTrials.gov/show/NCT02796924 Completed University of Manitoba 2019-04-30
NCT02764476 Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder https://ClinicalTrials.gov/show/NCT02764476 Recruiting Stanford University 2021-12-31
NCT02761330 Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia https://ClinicalTrials.gov/show/NCT02761330 Completed Washington University School of Medicine 2019-09-11
NCT02748915 Electrophysiological-based Estimation of Cochlear Implant Fitting https://ClinicalTrials.gov/show/NCT02748915 Recruiting Hospices Civils de Lyon 2020-07-31
NCT02727816 Non-dispensing Fitting Study Comparing the Clinical Performance Hydrogel Sphere Design Contact Lenses. https://ClinicalTrials.gov/show/NCT02727816 Completed Coopervision, Inc. 2016-05-31
NCT02726074 Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization https://ClinicalTrials.gov/show/NCT02726074 Completed Eisai Inc. 2018-04-26
NCT02724423 Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects https://ClinicalTrials.gov/show/NCT02724423 Completed Neurelis, Inc. 2019-04-10
NCT02721069 Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects https://ClinicalTrials.gov/show/NCT02721069 Recruiting Neurelis, Inc. 2020-05-31
NCT02700412 University of Alabama at Birmingham (UAB) Adult CBD Program https://ClinicalTrials.gov/show/NCT02700412 Completed University of Alabama at Birmingham 2019-08-08
NCT02695537 University of Alabama at Birmingham (UAB) Pediatric CBD Program https://ClinicalTrials.gov/show/NCT02695537 Completed University of Alabama at Birmingham 2019-02-27
NCT02598076 Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures https://ClinicalTrials.gov/show/NCT02598076 Completed Brigham and Women’s Hospital 2017-06-30
NCT02408549 Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures https://ClinicalTrials.gov/show/NCT02408549 Active, not recruiting UCB Pharma 2023-12-31
NCT02569970 Efficacy of Fluoxetine Against Seizure-induced Central Apneas https://ClinicalTrials.gov/show/NCT02569970 Completed Hospices Civils de Lyon 2010-12-31
NCT03399318 Aggressive Antipyretics for Fever Reduction in CNS Malaria https://ClinicalTrials.gov/show/NCT03399318 Recruiting University of Rochester 2022-03-31
NCT02550028 Levetiracetam Treatment of Neonatal Seizures https://ClinicalTrials.gov/show/NCT02550028 Active, not recruiting Children’s Hospital of Fudan University 2019-12-31
NCT02544763 A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) https://ClinicalTrials.gov/show/NCT02544763 Completed GW Research Ltd 2019-01-22
NCT02544750 An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) https://ClinicalTrials.gov/show/NCT02544750 Enrolling by invitation GW Research Ltd 2022-02-28
NCT02535572 Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment https://ClinicalTrials.gov/show/NCT02535572 Completed Medical University of South Carolina 2019-06-10
NCT02535091 Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT02535091 Active, not recruiting SK Life Science, Inc. 2020-12-31
NCT02484001 Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures https://ClinicalTrials.gov/show/NCT02484001 Completed Bial - Portela C S.A. 2018-09-11
NCT02477839 Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT02477839 Completed UCB Pharma 2020-05-28
NCT02465047 Stress and Seizures - Can a Brief Self-help Book Help? https://ClinicalTrials.gov/show/NCT02465047 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2015-09-30
NCT02458820 Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest https://ClinicalTrials.gov/show/NCT02458820 Completed Children’s Hospital of Philadelphia 2019-01-31
NCT02431780 A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection https://ClinicalTrials.gov/show/NCT02431780 Active, not recruiting University College Cork 2017-02-28
NCT02426047 Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy https://ClinicalTrials.gov/show/NCT02426047 Completed Johns Hopkins University 2020-01-31
NCT02408523 A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications https://ClinicalTrials.gov/show/NCT02408523 Completed UCB Pharma 2019-04-30
NCT02369471 A Study of GWP42006 in People With Focal Seizures - Part A https://ClinicalTrials.gov/show/NCT02369471 Completed GW Research Ltd 2015-10-31
NCT02365610 A Study of GWP42006 in People With Focal Seizures - Part B https://ClinicalTrials.gov/show/NCT02365610 Completed GW Research Ltd 2017-07-31
NCT02363933 Perampanel in Seizure Patients With Primary Glial Brain Tumors https://ClinicalTrials.gov/show/NCT02363933 Completed Duke University 2017-03-14
NCT02341859 Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1® https://ClinicalTrials.gov/show/NCT02341859 Completed Coopervision, Inc. 2015-06-30
NCT02339376 Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation https://ClinicalTrials.gov/show/NCT02339376 Active, not recruiting Beth Israel Deaconess Medical Center 2020-01-31
NCT02334722 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients https://ClinicalTrials.gov/show/NCT02334722 Recruiting University of Florida 2021-03-31
NCT02332174 Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects https://ClinicalTrials.gov/show/NCT02332174 Completed Wuhan Union Hospital, China 2014-06-30
NCT02325544 Comparing Different Treatments in Reducing Dissociative Seizure Occurrence https://ClinicalTrials.gov/show/NCT02325544 Completed King’s College London 2017-05-31
NCT02324673 Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders https://ClinicalTrials.gov/show/NCT02324673 Completed INSYS Therapeutics Inc 2016-05-09
NCT02318602 Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder https://ClinicalTrials.gov/show/NCT02318602 Completed INSYS Therapeutics Inc 2017-06-22
NCT02229318 A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet. https://ClinicalTrials.gov/show/NCT02229318 Completed Vitaflo International, Ltd 2014-10-31
NCT02224690 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults https://ClinicalTrials.gov/show/NCT02224690 Completed GW Research Ltd 2016-03-18
NCT02216500 Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy https://ClinicalTrials.gov/show/NCT02216500 Recruiting University of Florida 2020-10-31
NCT02224560 Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults https://ClinicalTrials.gov/show/NCT02224560 Completed GW Research Ltd 2016-05-19
NCT02192814 Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT02192814 Completed UCB Pharma 2014-10-31
NCT02124564 A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT02124564 Completed UCB Pharma 2017-11-21
NCT03384628 An Evaluation Of The Fitting Success Rate Of Senofilcon A Soft Contact Lenses In Three Designs. https://ClinicalTrials.gov/show/NCT03384628 Completed Visioncare Research Ltd. 2018-05-24
NCT02072824 A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT02072824 Completed Pfizer 2018-03-13
NCT01292837 A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT01292837 Completed UCB Pharma 2013-06-30
NCT01284556 Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01284556 Completed West-Ward Pharmaceutical 2013-01-31
NCT01278173 A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) https://ClinicalTrials.gov/show/NCT01278173 Completed Lundbeck LLC 2015-05-31
NCT00616681 Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions https://ClinicalTrials.gov/show/NCT00616681 Completed West-Ward Pharmaceutical 2004-07-31
NCT02019667 Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency https://ClinicalTrials.gov/show/NCT02019667 Completed National Institutes of Health Clinical Center (CC) 2019-01-31
NCT03325439 A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures https://ClinicalTrials.gov/show/NCT03325439 Recruiting UCB Pharma 2021-12-31
NCT01999777 Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU https://ClinicalTrials.gov/show/NCT01999777 Completed UCB Pharma 2015-08-31
NCT01982812 A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM https://ClinicalTrials.gov/show/NCT01982812 Completed University of Rochester 2015-06-30
NCT01977651 A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide https://ClinicalTrials.gov/show/NCT01977651 Completed Astellas Pharma Inc 2016-02-01
NCT01969851 A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. https://ClinicalTrials.gov/show/NCT01969851 Completed UCB Pharma 2018-04-10
NCT01963208 Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension https://ClinicalTrials.gov/show/NCT01963208 Completed Marinus Pharmaceuticals 2016-05-31
NCT01954121 Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures https://ClinicalTrials.gov/show/NCT01954121 Completed UCB Pharma 2015-09-30
NCT01941706 Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT https://ClinicalTrials.gov/show/NCT01941706 Completed Emory University 2011-12-31
NCT01921205 Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01921205 Completed UCB Pharma 2017-01-24
NCT01919307 Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures https://ClinicalTrials.gov/show/NCT01919307 Completed Denver Health and Hospital Authority 2016-01-31
NCT01892605 The Clinical Application and Mechanism of Music Therapy (Mozart’s Effect) on Epilepsy https://ClinicalTrials.gov/show/NCT01892605 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2011-10-31
NCT01866111 A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01866111 Active, not recruiting SK Life Science, Inc. 2015-07-31
NCT01856335 Exercise Education for Adults With Seizure Disorders https://ClinicalTrials.gov/show/NCT01856335 Completed National Institutes of Health Clinical Center (CC) 2017-01-25
NCT01834482 Modified Atkins Diet Plus KetoCal for Adult Epilepsy https://ClinicalTrials.gov/show/NCT01834482 Completed Johns Hopkins University 2017-09-30
NCT01832038 Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT01832038 Completed UCB Pharma 2019-07-31
NCT01831063 A Simulation-based Intervention for Caregivers of Children With Seizures https://ClinicalTrials.gov/show/NCT01831063 Completed University of Calgary 2012-12-31
NCT01801072 Seizure Prophylaxis in Aneurysm Repair https://ClinicalTrials.gov/show/NCT01801072 Active, not recruiting University of Michigan 2020-06-30
NCT01796574 Ketogenic Diet for Refractory Status Epilepticus https://ClinicalTrials.gov/show/NCT01796574 Completed Johns Hopkins University 2017-03-31
NCT01777139 A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01777139 Completed GlaxoSmithKline 2016-12-14
NCT01749046 Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT01749046 Completed Valexfarm 2013-10-31
NCT01720667 Efficacy of Intravenous Levetiracetam in Neonatal Seizures https://ClinicalTrials.gov/show/NCT01720667 Completed University of California, San Diego 2017-10-31
NCT01713946 A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures https://ClinicalTrials.gov/show/NCT01713946 Completed Novartis 2017-10-25
NCT01710657 A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures https://ClinicalTrials.gov/show/NCT01710657 Completed UCB Pharma 2014-07-31
NCT01703468 Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions https://ClinicalTrials.gov/show/NCT01703468 Completed West-Ward Pharmaceutical 2009-09-30
NCT01702623 Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions https://ClinicalTrials.gov/show/NCT01702623 Completed West-Ward Pharmaceutical 2009-09-30
NCT01660672 Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria https://ClinicalTrials.gov/show/NCT01660672 Completed University of Rochester 2013-07-31
NCT01657084 Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask https://ClinicalTrials.gov/show/NCT01657084 Completed University of Aarhus 2015-09-30
NCT01630057 Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug https://ClinicalTrials.gov/show/NCT01630057 Completed Eisai Inc. 2011-06-30
NCT01618695 A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures https://ClinicalTrials.gov/show/NCT01618695 Active, not recruiting Eisai Inc. 2014-09-15
NCT01601314 Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients https://ClinicalTrials.gov/show/NCT01601314 Completed Fundacion Clinic per a la Recerca Biomédica 2017-12-31
NCT01596608 Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder https://ClinicalTrials.gov/show/NCT01596608 Completed Centre for Addiction and Mental Health 2019-06-30
NCT00826722 Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions https://ClinicalTrials.gov/show/NCT00826722 Completed West-Ward Pharmaceutical 2007-06-30
NCT01554683 Seizure Activity in Alzheimer’s Disease https://ClinicalTrials.gov/show/NCT01554683 Completed Beth Israel Deaconess Medical Center 2017-07-01
NCT01527513 Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01527513 Completed Bial - Portela C S.A. 2012-03-31
NCT01515436 The Effect of Music Periodicity on Interictal Epileptiform Discharges https://ClinicalTrials.gov/show/NCT01515436 Completed Medical University of South Carolina 2004-05-31
NCT01506882 An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy https://ClinicalTrials.gov/show/NCT01506882 Completed UCB Pharma 2013-10-31
NCT01463306 A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures https://ClinicalTrials.gov/show/NCT01463306 Completed Pfizer 2019-08-22
NCT01459692 Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps https://ClinicalTrials.gov/show/NCT01459692 Completed Medical University of South Carolina 2008-01-31
NCT01458522 Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures https://ClinicalTrials.gov/show/NCT01458522 Completed Duke University 2014-07-31
NCT01441674 Animal Assisted Therapy in a Pediatric Setting https://ClinicalTrials.gov/show/NCT01441674 Completed Children’s Hospitals and Clinics of Minnesota 2013-12-31
NCT01434225 NEMO1:NEonatal Seizure Using Medication Off-patent https://ClinicalTrials.gov/show/NCT01434225 Completed Great Ormond Street Hospital for Children NHS Foundation Trust 2013-06-30
NCT01431976 Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents https://ClinicalTrials.gov/show/NCT01431976 Completed GlaxoSmithKline 2014-02-28
NCT01422720 Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients https://ClinicalTrials.gov/show/NCT01422720 Completed Bial - Portela C S.A. 2013-09-30
NCT01417078 A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode https://ClinicalTrials.gov/show/NCT01417078 Completed Acorda Therapeutics 2013-02-28
NCT01415362 Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy https://ClinicalTrials.gov/show/NCT01415362 Completed Spaulding Rehabilitation Hospital 2014-07-31
NCT01407523 An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01407523 Completed UCB Pharma 2012-02-29
NCT01398956 An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT01398956 Completed UCB Pharma 2016-04-30
NCT01397968 Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01397968 Active, not recruiting SK Life Science, Inc. 2013-06-30
NCT01393743 A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures https://ClinicalTrials.gov/show/NCT01393743 Completed Eisai Inc. 2014-05-31
NCT01392768 Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization https://ClinicalTrials.gov/show/NCT01392768 Completed Ache Laboratorios Farmaceuticos S.A. 2015-07-31
NCT01389596 A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years https://ClinicalTrials.gov/show/NCT01389596 Completed Pfizer 2016-08-10
NCT01345097 A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients https://ClinicalTrials.gov/show/NCT01345097 Completed Ewha Womans University 2006-03-31
NCT01338805 Phase II BGG492 Capsule Extension for Partial Epilepsy https://ClinicalTrials.gov/show/NCT01338805 Completed Novartis 2012-07-31
NCT01336621 Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) https://ClinicalTrials.gov/show/NCT01336621 Completed GlaxoSmithKline 2016-12-14
NCT01964560 Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01964560 Active, not recruiting UCB Pharma 2022-04-30
NCT04325685 The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia https://ClinicalTrials.gov/show/NCT04325685 Active, not recruiting Northern State Medical University 2021-12-31
NCT04323150 The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. https://ClinicalTrials.gov/show/NCT04323150 Recruiting Northern State Medical University 2020-12-31
NCT04311151 Impact of Self-visualization of Epileptic Seizures on Patients’ Perception of the Disease and Risk Behavior https://ClinicalTrials.gov/show/NCT04311151 Completed Parc de Salut Mar 2019-05-31
NCT01325623 Seizure Detection and Automatic Magnet Mode Performance Study https://ClinicalTrials.gov/show/NCT01325623 Completed Cyberonics, Inc. 2013-07-31
NCT04266990 Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat. https://ClinicalTrials.gov/show/NCT04266990 Recruiting University Hospital, Ghent 2020-06-01
NCT04244175 A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures https://ClinicalTrials.gov/show/NCT04244175 Active, not recruiting Cerevel Therapeutics, LLC 2021-09-01
NCT04211233 Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE) https://ClinicalTrials.gov/show/NCT04211233 Recruiting University Clinic Frankfurt 2020-12-20
NCT04158531 REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex. https://ClinicalTrials.gov/show/NCT04158531 Recruiting UMC Utrecht 2022-03-31
NCT04144439 Effect of GABA on ADHD and Seizures in Children With Epilepsy. https://ClinicalTrials.gov/show/NCT04144439 Recruiting Tanta University 2028-12-01
NCT04141891 Advancing Understanding of Transportation Options https://ClinicalTrials.gov/show/NCT04141891 Recruiting University of Colorado, Denver 2023-08-01
NCT04095182 Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult https://ClinicalTrials.gov/show/NCT04095182 Completed Whanin Pharmaceutical Company 2019-12-16
NCT04015141 A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy https://ClinicalTrials.gov/show/NCT04015141 Recruiting Eisai Inc. 2021-10-13
NCT03961568 Cenobamate Open-Label Extension Study for YKP3089C025 https://ClinicalTrials.gov/show/NCT03961568 Enrolling by invitation SK Life Science, Inc. 2023-05-31
NCT03954314 DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery https://ClinicalTrials.gov/show/NCT03954314 Recruiting Population Health Research Institute 2021-11-30
NCT03944447 Outcomes Mandate National Integration With Cannabis as Medicine https://ClinicalTrials.gov/show/NCT03944447 Recruiting OMNI Medical Services, LLC 2025-12-31
NCT03940326 Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT03940326 Active, not recruiting Mazandaran University of Medical Sciences 2019-10-01
NCT03909984 Promoting Implementation of Seizure Detection Devices in Epilepsy Care https://ClinicalTrials.gov/show/NCT03909984 Recruiting Stichting Epilepsie Instellingen Nederland 2021-12-31
NCT03896386 EPIDOGS Digital Seizure Diary for Owners of Alerting Dogs https://ClinicalTrials.gov/show/NCT03896386 Recruiting University Hospital, Ghent 2020-06-30
NCT03882671 Development of a Minimally Invasive Seizure Gauge https://ClinicalTrials.gov/show/NCT03882671 Enrolling by invitation Seer Medical Pty Ltd 2020-12-01
NCT03790436 Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet https://ClinicalTrials.gov/show/NCT03790436 Recruiting University of Southern California 2020-12-30
NCT03780907 Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy https://ClinicalTrials.gov/show/NCT03780907 Completed Eisai Inc. 2003-08-06
NCT03754582 A Study of Intravenous Perampanel in Japanese Participants With Epilepsy https://ClinicalTrials.gov/show/NCT03754582 Completed Eisai Inc. 2019-12-10
NCT03745118 Development of a Practical, Minimally Invasive Seizure Gauge https://ClinicalTrials.gov/show/NCT03745118 Enrolling by invitation Mayo Clinic 2020-12-01
NCT03742661 Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis https://ClinicalTrials.gov/show/NCT03742661 Active, not recruiting Brain Sentinel 2021-01-31
NCT03722212 Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test https://ClinicalTrials.gov/show/NCT03722212 Recruiting METAFORA biosystems 2020-12-31
NCT03712475 Pharmacokinetics of Two Formulation of Pregabalin https://ClinicalTrials.gov/show/NCT03712475 Completed Yung Shin Pharm. Ind. Co., Ltd. 2018-09-16
NCT03685630 A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization https://ClinicalTrials.gov/show/NCT03685630 Recruiting UCB Pharma 2021-03-31
NCT03678753 Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures https://ClinicalTrials.gov/show/NCT03678753 Recruiting SK Life Science, Inc. 2021-11-19
NCT03676543 Mutual Interactions Between Absence Epilepsy Seizures and the Integration of Sensory Stimuli https://ClinicalTrials.gov/show/NCT03676543 Recruiting Fondation Ophtalmologique Adolphe de Rothschild 2020-06-30
NCT03631901 Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures https://ClinicalTrials.gov/show/NCT03631901 Completed Tanta University 2018-09-01
NCT03590197 Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Seizure https://ClinicalTrials.gov/show/NCT03590197 Completed All India Institute of Medical Sciences, Bhubaneswar 2020-03-03
NCT03562351 Seizure Rescue Medication: Caregiver Education in a Simulation Setting https://ClinicalTrials.gov/show/NCT03562351 Recruiting Boston Children’s Hospital 2021-05-31
NCT03548779 North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 https://ClinicalTrials.gov/show/NCT03548779 Recruiting University of North Carolina, Chapel Hill 2021-05-31
NCT03513757 Dexmedetomidine and Propofol for Pediatric MRI Sedation https://ClinicalTrials.gov/show/NCT03513757 Completed Medical College of Wisconsin 2018-08-21
NCT03484039 Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy https://ClinicalTrials.gov/show/NCT03484039 Recruiting University of Florida 2021-02-28
NCT03480555 Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients https://ClinicalTrials.gov/show/NCT03480555 Completed King Abdullah International Medical Research Center 2019-05-10
NCT03478982 Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern https://ClinicalTrials.gov/show/NCT03478982 Active, not recruiting EngageTherapeutics, Inc. 2019-12-31
NCT03441867 Neuroimaging Biomarker for Seizures https://ClinicalTrials.gov/show/NCT03441867 Recruiting Providence VA Medical Center 2021-03-31
NCT03443388 Novel Helmet Design in Patients With Seizures https://ClinicalTrials.gov/show/NCT03443388 Completed University of Pennsylvania 2019-12-15
NCT03417297 A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy https://ClinicalTrials.gov/show/NCT03417297 Recruiting Ohio State University 2020-03-31
NCT01262677 Once-A-Day Pregabalin For Partial Seizures https://ClinicalTrials.gov/show/NCT01262677 Completed Pfizer 2012-07-31
NCT01261325 Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01261325 Completed UCB Pharma 2014-05-31
NCT01239212 Dosing of Levetiracetam (Keppra) in Neonates https://ClinicalTrials.gov/show/NCT01239212 Completed Children’s Hospital Medical Center, Cincinnati 2011-07-31
NCT01229735 Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01229735 Completed UCB Pharma 2015-05-31
NCT01228747 A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) https://ClinicalTrials.gov/show/NCT01228747 Completed UCB Pharma 2014-04-30
NCT01227902 Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures https://ClinicalTrials.gov/show/NCT01227902 Completed GlaxoSmithKline 2012-12-31
NCT01224457 Effect of CYP2C9/CYP2C19 Polymorphism on Pharmacokinetics of Phenobarbital in Korean Neonatal Seizure Patients. https://ClinicalTrials.gov/show/NCT01224457 Completed Yonsei University 2010-04-30
NCT01191086 Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures https://ClinicalTrials.gov/show/NCT01191086 Completed Upsher-Smith Laboratories 2014-05-31
NCT01179854 Remegal Different Doses in Patients With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT01179854 Completed Valexfarm 2010-11-30
NCT01162460 Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures https://ClinicalTrials.gov/show/NCT01162460 Completed Bial - Portela C S.A. 2016-09-30
NCT01159431 External Trigeminal Nerve Stimulation for Epilepsy https://ClinicalTrials.gov/show/NCT01159431 Completed Olive View-UCLA Education & Research Institute 2011-06-30
NCT01147003 Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01147003 Completed Novartis 2011-09-30
NCT01142193 Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures https://ClinicalTrials.gov/show/NCT01142193 Completed Upsher-Smith Laboratories 2012-12-31
NCT01137110 Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH https://ClinicalTrials.gov/show/NCT01137110 Completed Washington University School of Medicine 2013-01-01
NCT01136954 A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) https://ClinicalTrials.gov/show/NCT01136954 Completed Eisai Inc. 2012-01-31
NCT01118962 Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy https://ClinicalTrials.gov/show/NCT01118962 Completed UCB Pharma 2012-10-31
NCT01118949 Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy https://ClinicalTrials.gov/show/NCT01118949 Completed UCB Pharma 2011-08-31
NCT01116700 Dexmedetomidine in Seizure Patients https://ClinicalTrials.gov/show/NCT01116700 Completed University of California, San Francisco 2012-02-29
NCT01063764 An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT01063764 Completed UCB Pharma 2011-04-30
NCT01051193 Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures https://ClinicalTrials.gov/show/NCT01051193 Completed Nobelpharma 2019-09-30
NCT01027715 The Impact of Electroencephalographic (EEG) Seizure Treatment in Neonatal Encephalopathy https://ClinicalTrials.gov/show/NCT01027715 Completed Washington University School of Medicine 2015-12-31
NCT00991757 An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT00991757 Completed SK Life Science, Inc. 2010-10-31
NCT00988429 Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00988429 Active, not recruiting Bial - Portela C S.A. 2012-01-12
NCT00988156 Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children https://ClinicalTrials.gov/show/NCT00988156 Completed Bial - Portela C S.A. 2012-08-20
NCT00975715 Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00975715 Completed Novartis 2012-10-31
NCT00973934 Magnetic Seizure Therapy (MST) for the Treatment of Major Depression https://ClinicalTrials.gov/show/NCT00973934 Completed Duke University 2006-01-31
NCT00957684 Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00957684 Completed Bial - Portela C S.A. 2005-11-30
NCT00946751 To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions https://ClinicalTrials.gov/show/NCT00946751 Completed Sandoz 2004-03-31
NCT00938431 A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures https://ClinicalTrials.gov/show/NCT00938431 Completed UCB Pharma 2014-08-31
NCT00914680 Berlin Magnetic Seizure Therapy Depression Trial 01 https://ClinicalTrials.gov/show/NCT00914680 Completed Charite University, Berlin, Germany 2012-05-31
NCT00903786 A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs) https://ClinicalTrials.gov/show/NCT00903786 Completed Eisai Inc. 2016-08-08
NCT00887861 Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery https://ClinicalTrials.gov/show/NCT00887861 Completed Novartis 2010-08-31
NCT00884052 Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures https://ClinicalTrials.gov/show/NCT00884052 Completed University of California, San Diego 2011-03-31
NCT00880204 Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training https://ClinicalTrials.gov/show/NCT00880204 Completed Child Advocacy International 2009-09-30
NCT00871377 Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures https://ClinicalTrials.gov/show/NCT00871377 Completed National Center for Complementary and Integrative Health (NCCIH) 2011-05-31
NCT00866775 Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs https://ClinicalTrials.gov/show/NCT00866775 Completed Sunovion 2013-05-31
NCT00864006 Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions https://ClinicalTrials.gov/show/NCT00864006 Completed Sandoz 2006-10-31
NCT00849212 An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs) https://ClinicalTrials.gov/show/NCT00849212 Completed Eisai Inc. 2009-11-30
NCT00848549 Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures https://ClinicalTrials.gov/show/NCT00848549 Completed Eisai Inc. 2011-06-30
NCT03310697 Toxicological Screening by GC-MS Among Children Admitted for a First Afebrile Seizure https://ClinicalTrials.gov/show/NCT03310697 Recruiting University Hospital, Toulouse 2020-12-31
NCT00835627 Treatment Trial for Psychogenic Nonepileptic Seizures https://ClinicalTrials.gov/show/NCT00835627 Completed Rhode Island Hospital 2012-12-31
NCT00830531 Pilot Study of Bumetanide for Newborn Seizures https://ClinicalTrials.gov/show/NCT00830531 Completed Soul, Janet , M.D. 2019-01-31
NCT00827320 Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions https://ClinicalTrials.gov/show/NCT00827320 Completed West-Ward Pharmaceutical 2007-06-30
NCT00826865 Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions https://ClinicalTrials.gov/show/NCT00826865 Completed West-Ward Pharmaceutical 2005-08-31
NCT00826787 Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions https://ClinicalTrials.gov/show/NCT00826787 Completed West-Ward Pharmaceutical 2005-08-31
NCT04219995 Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy https://ClinicalTrials.gov/show/NCT04219995 Recruiting Louisiana State University Health Sciences Center in New Orleans 2021-02-28
NCT03054285 Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates? https://ClinicalTrials.gov/show/NCT03054285 Recruiting Loyola University 2020-04-01
NCT02849626 Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures https://ClinicalTrials.gov/show/NCT02849626 Active, not recruiting Eisai Inc. 2019-02-05
NCT00808938 A Pilot Study of the Use of Magnetic Seizure Therapy for Depression https://ClinicalTrials.gov/show/NCT00808938 Completed Bayside Health 2011-01-31
NCT01747915 A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. https://ClinicalTrials.gov/show/NCT01747915 Completed Pfizer 2019-02-20
NCT03235115 Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses https://ClinicalTrials.gov/show/NCT03235115 Completed Coopervision, Inc. 2017-09-22
NCT02705768 Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures https://ClinicalTrials.gov/show/NCT02705768 Completed All India Institute of Medical Sciences, Bhubaneswar 2017-02-28
NCT02682927 A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome https://ClinicalTrials.gov/show/NCT02682927 Active, not recruiting Zogenix, Inc. 2020-07-31
NCT01869374 Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults https://ClinicalTrials.gov/show/NCT01869374 Active, not recruiting New York State Psychiatric Institute 2017-07-31
NCT01521130 Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children https://ClinicalTrials.gov/show/NCT01521130 Completed Children’s Hospital Medical Center, Cincinnati 2017-07-31
NCT00955357 Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00955357 Completed UCB Pharma 2013-04-30
NCT00789113 Determination of Absorption and Elimination of Lamotrigine-XR https://ClinicalTrials.gov/show/NCT00789113 Completed University of Minnesota 2011-01-31
NCT00772603 Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures https://ClinicalTrials.gov/show/NCT00772603 Completed Supernus Pharmaceuticals, Inc. 2010-04-30
NCT00770783 Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression https://ClinicalTrials.gov/show/NCT00770783 Completed University Hospital, Bonn 2013-09-30
NCT00744731 An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00744731 Completed SK Life Science, Inc. 2010-08-31
NCT00740623 A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT00740623 Completed SK Life Science, Inc. 2009-10-31
NCT00735527 Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children https://ClinicalTrials.gov/show/NCT00735527 Completed All India Institute of Medical Sciences, New Delhi 2009-04-30
NCT00735397 Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00735397 Completed Eisai Inc. 2014-09-30
NCT00700310 Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00700310 Completed Eisai Inc. 2009-08-31
NCT00699582 To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00699582 Completed Eisai Inc. 2010-12-31
NCT00699972 Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00699972 Completed Eisai Inc. 2010-10-19
NCT00697918 Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00697918 Completed SK Life Science, Inc. 2009-04-30
NCT00659958 ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs https://ClinicalTrials.gov/show/NCT00659958 Completed Eisai Inc. 2009-09-30
NCT00655551 Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00655551 Completed UCB Pharma 2009-09-30
NCT00655486 Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00655486 Completed UCB Pharma 2010-06-30
NCT00643136 A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures https://ClinicalTrials.gov/show/NCT00643136 Completed Pfizer NA
NCT00629889 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors https://ClinicalTrials.gov/show/NCT00629889 Completed Centre Hospitalier Universitaire Vaudois 2012-05-31
NCT00618436 Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention https://ClinicalTrials.gov/show/NCT00618436 Completed University of Cincinnati 2009-09-30
NCT00618046 Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions https://ClinicalTrials.gov/show/NCT00618046 Completed West-Ward Pharmaceutical 2004-11-30
NCT00616863 Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions https://ClinicalTrials.gov/show/NCT00616863 Completed West-Ward Pharmaceutical 2004-07-31
NCT00616759 The Effect on Cognition of Terminating ECT Induced Seizures With Propofol https://ClinicalTrials.gov/show/NCT00616759 Completed Loma Linda University 2008-09-30
NCT00615615 Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00615615 Completed UCB Pharma 2003-03-31
NCT00610454 Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00610454 Completed UCB Pharma 2004-08-31
NCT00603473 A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00603473 Completed Pfizer 2009-12-31
NCT00596466 Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00596466 Completed Pfizer 2011-12-31
NCT00594945 Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures https://ClinicalTrials.gov/show/NCT00594945 Completed Jazz Pharmaceuticals 2008-12-31
NCT00571155 Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery https://ClinicalTrials.gov/show/NCT00571155 Completed University Hospital Tuebingen 2009-08-31
NCT00568217 Antipyretics for Preventing Recurrences of Febrile Seizures https://ClinicalTrials.gov/show/NCT00568217 Completed University of Oulu NA
NCT00566254 Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study) https://ClinicalTrials.gov/show/NCT00566254 Completed Eisai Inc. 2011-03-31
NCT00552305 To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00552305 Completed UCB Pharma 2010-02-28
NCT00545012 A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures https://ClinicalTrials.gov/show/NCT00545012 Completed UCB Pharma 2003-05-31
NCT00537940 Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures https://ClinicalTrials.gov/show/NCT00537940 Completed Pfizer 2013-07-31
NCT00537238 Pregabalin Versus Levetiracetam In Partial Seizures https://ClinicalTrials.gov/show/NCT00537238 Completed Pfizer 2012-05-31
NCT00534378 Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector https://ClinicalTrials.gov/show/NCT00534378 Completed U.S. Army Office of the Surgeon General NA
NCT00530855 Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00530855 Completed UCB Pharma 2014-12-31
NCT00522275 Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00522275 Completed UCB Pharma 2009-10-31
NCT00520741 Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00520741 Completed UCB Pharma 2012-12-31
NCT00518713 Clobazam in Patients With Lennox-Gastaut Syndrome https://ClinicalTrials.gov/show/NCT00518713 Completed Lundbeck LLC 2009-12-31
NCT00515619 Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00515619 Completed UCB Pharma 2010-08-31
NCT00510783 IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures https://ClinicalTrials.gov/show/NCT00510783 Completed Emory University 2008-12-31
NCT00500994 Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures https://ClinicalTrials.gov/show/NCT00500994 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT00490035 Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00490035 Completed UCB Pharma 2009-02-28
NCT00488748 Magnetic Seizure Therapy (MST) for Severe Mood Disorder https://ClinicalTrials.gov/show/NCT00488748 Completed Duke University 2012-08-31
NCT00465517 A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures https://ClinicalTrials.gov/show/NCT00465517 Completed Marinus Pharmaceuticals 2008-10-31
NCT00464269 Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00464269 Completed UCB Pharma 2008-12-31
NCT00448916 Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures https://ClinicalTrials.gov/show/NCT00448916 Completed Pfizer 2013-10-31
NCT00437281 Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00437281 Completed Pfizer 2012-11-30
NCT00433667 A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT00433667 Completed SK Life Science, Inc. 2007-10-31
NCT00425282 A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT00425282 Completed SK Life Science, Inc. 2007-10-31
NCT00419393 Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures https://ClinicalTrials.gov/show/NCT00419393 Completed UCB Pharma 2010-03-31
NCT00419094 Conversion to Monotherapy Study With Keppra XR for Partial Seizures https://ClinicalTrials.gov/show/NCT00419094 Completed UCB Pharma 2009-09-30
NCT00416195 Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00416195 Completed Eisai Inc. 2008-02-29
NCT00368472 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00368472 Completed Eisai Inc. 2014-06-30
NCT00367432 A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00367432 Completed UCB Pharma 2010-12-31
NCT00361010 A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy https://ClinicalTrials.gov/show/NCT00361010 Completed The Cleveland Clinic 2007-12-31
NCT00351611 Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo https://ClinicalTrials.gov/show/NCT00351611 Recruiting Pfizer 2020-11-11
NCT00334958 Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00334958 Completed Eisai Inc. 2009-05-31
NCT00327717 Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures https://ClinicalTrials.gov/show/NCT00327717 Completed Eisai Inc. 2008-05-31
NCT00326612 Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures https://ClinicalTrials.gov/show/NCT00326612 Completed University of Utah 2008-12-31
NCT00319501 Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. https://ClinicalTrials.gov/show/NCT00319501 Completed Pfizer 2014-07-31
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly https://ClinicalTrials.gov/show/NCT00318929 Completed Virginia Commonwealth University 2008-01-31
NCT00298532 OPALS Pediatric Study https://ClinicalTrials.gov/show/NCT00298532 Completed Ottawa Hospital Research Institute 2007-01-31
NCT00292461 A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures https://ClinicalTrials.gov/show/NCT00292461 Completed Eisai Inc. 2009-08-31
NCT00290823 Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients https://ClinicalTrials.gov/show/NCT00290823 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-03-31
NCT00288639 Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER). https://ClinicalTrials.gov/show/NCT00288639 Completed Pfizer 2007-12-31
NCT00285285 Point of Care Device Use in the Pediatric Emergency Department https://ClinicalTrials.gov/show/NCT00285285 Completed Yale University NA
NCT00280696 A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00280696 Completed UCB Pharma 2007-11-30
NCT00275925 Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures https://ClinicalTrials.gov/show/NCT00275925 Completed Novartis NA
NCT00275912 Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures https://ClinicalTrials.gov/show/NCT00275912 Completed Novartis 2007-09-28
NCT00266604 A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy https://ClinicalTrials.gov/show/NCT00266604 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00266591 A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy https://ClinicalTrials.gov/show/NCT00266591 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236886 Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients https://ClinicalTrials.gov/show/NCT00236886 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236873 A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. https://ClinicalTrials.gov/show/NCT00236873 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236860 A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00236860 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236847 A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. https://ClinicalTrials.gov/show/NCT00236847 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236756 A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome https://ClinicalTrials.gov/show/NCT00236756 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236743 A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy https://ClinicalTrials.gov/show/NCT00236743 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236730 A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy https://ClinicalTrials.gov/show/NCT00236730 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236717 A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy https://ClinicalTrials.gov/show/NCT00236717 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236704 A Study of the Efficacy and Safety of Topiramate as “Add on” Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT00236704 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236691 A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. https://ClinicalTrials.gov/show/NCT00236691 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00236418 A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT00236418 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00235755 Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy https://ClinicalTrials.gov/show/NCT00235755 Completed GlaxoSmithKline 2008-04-30
NCT00233012 A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00233012 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00232596 Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy https://ClinicalTrials.gov/show/NCT00232596 Completed GlaxoSmithKline 2008-01-31
NCT00231556 A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy https://ClinicalTrials.gov/show/NCT00231556 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00230698 A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure https://ClinicalTrials.gov/show/NCT00230698 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00220415 A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization https://ClinicalTrials.gov/show/NCT00220415 Completed UCB Pharma 2006-01-31
NCT00215592 Open Label, Zonegran (Zonisamide) In Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00215592 Completed Eisai Inc. 2007-07-31
NCT00179517 Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo https://ClinicalTrials.gov/show/NCT00179517 Completed Beth Israel Deaconess Medical Center 2008-04-30
NCT00175929 A Study of Brivaracetam in Subjects With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00175929 Completed UCB Pharma 2006-03-31
NCT00175890 A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT00175890 Completed UCB Pharma 2007-01-31
NCT00175825 A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. https://ClinicalTrials.gov/show/NCT00175825 Completed UCB Pharma 2006-06-29
NCT00162981 Clobazam in Subjects With Lennox-Gastaut Syndrome https://ClinicalTrials.gov/show/NCT00162981 Completed Lundbeck LLC 2006-08-31
NCT00160615 Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method https://ClinicalTrials.gov/show/NCT00160615 Completed UCB Pharma 2007-01-17
NCT00160550 Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT00160550 Completed UCB Pharma 2005-06-30
NCT00159965 Treatments for Psychogenic Nonepileptic Seizures (NES) https://ClinicalTrials.gov/show/NCT00159965 Completed Rhode Island Hospital 2008-06-30
NCT00152516 Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00152516 Completed UCB Pharma 2008-06-30
NCT00152503 Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam https://ClinicalTrials.gov/show/NCT00152503 Completed UCB Pharma 2007-01-31
NCT00152451 Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00152451 Completed UCB Pharma 2007-01-31
NCT00151879 Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures https://ClinicalTrials.gov/show/NCT00151879 Completed UCB Pharma 2006-05-31
NCT00150293 Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. https://ClinicalTrials.gov/show/NCT00150293 Completed Pfizer NA
NCT00147030 TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia https://ClinicalTrials.gov/show/NCT00147030 Completed Imperial College London 2006-11-30
NCT00144872 LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures https://ClinicalTrials.gov/show/NCT00144872 Completed GlaxoSmithKline 2006-04-22
NCT00144690 E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures https://ClinicalTrials.gov/show/NCT00144690 Completed Eisai Inc. 2007-02-28
NCT00143143 Pregabalin Open-Label Extension Trial in Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00143143 Completed Pfizer NA
NCT00143130 Pregabalin In Partial Seizures Extension Study https://ClinicalTrials.gov/show/NCT00143130 Completed Pfizer NA
NCT00141427 Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial. https://ClinicalTrials.gov/show/NCT00141427 Completed Pfizer NA
NCT00141388 To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00141388 Completed Pfizer NA
NCT00141336 To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. https://ClinicalTrials.gov/show/NCT00141336 Completed Pfizer NA
NCT00141258 Pregabalin Epilepsy Add-On Trial https://ClinicalTrials.gov/show/NCT00141258 Completed Pfizer NA
NCT00141245 To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. https://ClinicalTrials.gov/show/NCT00141245 Completed Pfizer NA
NCT00136019 SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization https://ClinicalTrials.gov/show/NCT00136019 Completed UCB Pharma 2006-08-31
NCT00116064 Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions https://ClinicalTrials.gov/show/NCT00116064 Completed University of Malawi College of Medicine NA
NCT00113815 Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00113815 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2007-06-30
NCT00113165 Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures https://ClinicalTrials.gov/show/NCT00113165 Completed GlaxoSmithKline 2007-07-31
NCT00105040 A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT00105040 Completed UCB Pharma 2007-03-31
NCT00104416 Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures https://ClinicalTrials.gov/show/NCT00104416 Completed GlaxoSmithKline 2008-07-31
NCT00102713 A Study for Treatment of Partial Seizures in Children https://ClinicalTrials.gov/show/NCT00102713 Completed Abbott NA
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study https://ClinicalTrials.gov/show/NCT00088452 Completed Children’s Hospital Medical Center, Cincinnati 2013-01-31
NCT00067210 Reducing Seizure Frequency Using Cooling of the Head and Neck https://ClinicalTrials.gov/show/NCT00067210 Completed National Institutes of Health Clinical Center (CC) NA
NCT00034814 Multicenter Trial for Adults With Partial Seizures https://ClinicalTrials.gov/show/NCT00034814 Completed Teva Pharmaceutical Industries 2006-01-31
NCT00043901 Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug https://ClinicalTrials.gov/show/NCT00043901 Completed GlaxoSmithKline 2003-11-01
NCT00040326 Early Surgical Intervention to Treat Epilepsy https://ClinicalTrials.gov/show/NCT00040326 Completed University of California, Los Angeles 2007-11-30
NCT00007670 Does Gabapentin and Lamotriginel Have Significantly Fewer Side-Effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. https://ClinicalTrials.gov/show/NCT00007670 Completed VA Office of Research and Development NA
NCT00004817 Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures https://ClinicalTrials.gov/show/NCT00004817 Completed Office of Rare Diseases (ORD) NA
NCT00004729 Ketogenic Diet for Child Epilepsy and Seizure Control https://ClinicalTrials.gov/show/NCT00004729 Completed National Institute of Neurological Disorders and Stroke (NINDS) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03369522 Development of an Epileptic Seizure Detection Algorithm by Continuous Analysis of the Electrocardiogram https://ClinicalTrials.gov/show/NCT03369522 Recruiting University Hospital, Lille 2020-01-31
NCT03822741 Etiology and Treatment of Neonatal Seizure https://ClinicalTrials.gov/show/NCT03822741 Recruiting Children’s Hospital of Fudan University 2021-12-30
NCT03169751 An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures https://ClinicalTrials.gov/show/NCT03169751 Active, not recruiting Brain Sentinel 2020-02-01
NCT03123302 Our Anesthesia Experience During MRI Scan https://ClinicalTrials.gov/show/NCT03123302 Completed Akdeniz University 2018-02-01
NCT03103425 Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings https://ClinicalTrials.gov/show/NCT03103425 Completed Beth Israel Deaconess Medical Center 2014-06-01
NCT03059381 Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT03059381 Active, not recruiting Eisai Inc. 2022-02-28
NCT03059329 Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT03059329 Completed Eisai Inc. 2019-09-13
NCT03013348 Automated Identification of Psychogenic Nonepileptic Seizures https://ClinicalTrials.gov/show/NCT03013348 Active, not recruiting Brain Sentinel 2019-05-21
NCT02995759 Creation, Implementation, and Analysis of a Seizure Action Plan https://ClinicalTrials.gov/show/NCT02995759 Completed Boston Children’s Hospital 2019-04-30
NCT02926703 Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure https://ClinicalTrials.gov/show/NCT02926703 Completed RWTH Aachen University 2016-08-31
NCT02883712 Study of Predictors of Response to Anti Epilepsy in Epilepsy https://ClinicalTrials.gov/show/NCT02883712 Recruiting University Hospital, Lille 2021-12-31
NCT02819427 Concomitant High-resolution Recording of Haemodynamic and Electrical Activities of Children With Typical or Atypical Absence Seizures https://ClinicalTrials.gov/show/NCT02819427 Active, not recruiting Centre Hospitalier Universitaire, Amiens 2018-08-31
NCT02789176 Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study https://ClinicalTrials.gov/show/NCT02789176 Completed University of Michigan 2020-03-24
NCT02736162 Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy https://ClinicalTrials.gov/show/NCT02736162 Completed Eisai Inc. 2016-06-30
NCT01443611 The Relevance of Performing Lumbar Puncture in Infants Aged 3 to 12 Months With First Episode of Febrile Convulsion https://ClinicalTrials.gov/show/NCT01443611 Completed HaEmek Medical Center, Israel 2015-03-31
NCT02694094 Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy https://ClinicalTrials.gov/show/NCT02694094 Enrolling by invitation Johns Hopkins University 2022-12-31
NCT02687711 Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures https://ClinicalTrials.gov/show/NCT02687711 Active, not recruiting UCB Pharma 2020-07-31
NCT02824822 Genetic Markers of Cardiovascular Disease in Epilepsy https://ClinicalTrials.gov/show/NCT02824822 Recruiting Mayo Clinic 2022-12-31
NCT02813980 Neural Circulatory Control and SUDEP Risk. https://ClinicalTrials.gov/show/NCT02813980 Recruiting Mayo Clinic 2022-05-31
NCT02555410 Seizure Detection and Warning System in Epilepsy Patients https://ClinicalTrials.gov/show/NCT02555410 Completed Brain Sentinel 2017-07-07
NCT02552511 Epidemiology Study on Neonatal Seizure https://ClinicalTrials.gov/show/NCT02552511 Recruiting Children’s Hospital of Fudan University 2020-12-30
NCT02424123 Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults? https://ClinicalTrials.gov/show/NCT02424123 Recruiting Centre Hospitalier Universitaire de Nīmes 2021-10-31
NCT02392078 Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System https://ClinicalTrials.gov/show/NCT02392078 Recruiting Monteris Medical 2023-12-31
NCT02385526 Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation https://ClinicalTrials.gov/show/NCT02385526 Completed LivaNova 2016-10-10
NCT02371200 Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients https://ClinicalTrials.gov/show/NCT02371200 Completed Brain Sentinel 2017-12-31
NCT02349087 EEG in Resuscitated In-hospital Patients https://ClinicalTrials.gov/show/NCT02349087 Recruiting Kuopio University Hospital 2018-12-31
NCT02298647 Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) https://ClinicalTrials.gov/show/NCT02298647 Active, not recruiting Centogene AG Rostock 2021-08-31
NCT02286271 Preliminary Testing of a Novel Device to Detect Epileptic Seizures https://ClinicalTrials.gov/show/NCT02286271 Completed University of Edinburgh 2016-12-31
NCT02269397 Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures https://ClinicalTrials.gov/show/NCT02269397 Completed Cognizance Biomarkers, LLC 2015-07-14
NCT02160171 ANSeR- The Algorithm for Neonatal Seizure Recognition Study https://ClinicalTrials.gov/show/NCT02160171 Completed University College Cork 2015-06-30
NCT02082873 Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses https://ClinicalTrials.gov/show/NCT02082873 Completed Duke University 2019-02-28
NCT01318018 Investigation on the Value of Bilateral Index (BIS) Monitoring for Magnetic Seizure Versus Electroconvulsive Therapy https://ClinicalTrials.gov/show/NCT01318018 Completed University Hospital, Bonn 2011-12-31
NCT01291992 Seizures After Cardiac Surgery – A Study With Continuous EEG Monitoring https://ClinicalTrials.gov/show/NCT01291992 Completed Lawson Health Research Institute 2012-10-31
NCT01283256 A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures. https://ClinicalTrials.gov/show/NCT01283256 Completed Eisai Inc. 2013-01-31
NCT04202159 A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures https://ClinicalTrials.gov/show/NCT04202159 Recruiting Eisai Inc. 2021-12-01
NCT01931813 METHORIVAC - Vaccinal Pharmacoepidemiologic https://ClinicalTrials.gov/show/NCT01931813 Completed Centre Hospitalier Universitaire Dijon 2012-09-30
NCT01897974 Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia https://ClinicalTrials.gov/show/NCT01897974 Completed Nationwide Children’s Hospital 2014-06-30
NCT01884766 Copeptin in Childhood Epilepsy https://ClinicalTrials.gov/show/NCT01884766 Completed University Hospital, Basel, Switzerland 2015-12-31
NCT01874600 Seizure Detection and Warning System for Epilepsy Patients https://ClinicalTrials.gov/show/NCT01874600 Active, not recruiting Brain Sentinel 2019-12-31
NCT01855178 Pediatric Seizure Movement Bed Alarm https://ClinicalTrials.gov/show/NCT01855178 Completed Le Bonheur Children’s Hospital 2015-06-30
NCT01833247 Lactic Acidosis During and After Seizures https://ClinicalTrials.gov/show/NCT01833247 Completed Stanford University 2014-12-31
NCT01830868 A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM) https://ClinicalTrials.gov/show/NCT01830868 Completed Eisai Inc. 2013-06-30
NCT01830400 A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) https://ClinicalTrials.gov/show/NCT01830400 Completed Eisai Inc. 2014-03-31
NCT01747863 Prospective Research in Infants With Mild Encephalopathy https://ClinicalTrials.gov/show/NCT01747863 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2015-12-31
NCT01744301 Acid Suppressing Drug Seizure Epidemiology Study https://ClinicalTrials.gov/show/NCT01744301 Completed AstraZeneca 2014-12-31
NCT01694524 Nervous System Infections Among Patients With Febrile Seizure https://ClinicalTrials.gov/show/NCT01694524 Completed Hôpital Armand Trousseau 2014-03-31
NCT01673282 Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy https://ClinicalTrials.gov/show/NCT01673282 Completed UCB Pharma 2015-07-31
NCT01620840 Lacosamid-i.v.-Register https://ClinicalTrials.gov/show/NCT01620840 Completed University of Schleswig-Holstein 2013-11-30
NCT01431326 Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care https://ClinicalTrials.gov/show/NCT01431326 Completed Duke University 2019-11-30
NCT01417507 Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery https://ClinicalTrials.gov/show/NCT01417507 Completed Radiation Therapy Oncology Group 2014-12-31
NCT01357707 Clinical-genetic Investigations in Children With Early Infantile Epilepsies https://ClinicalTrials.gov/show/NCT01357707 Completed Charite University, Berlin, Germany 2017-12-31
NCT01355211 Putting Electroencephalography (EEG) in the Emergency Department https://ClinicalTrials.gov/show/NCT01355211 Completed Bio-Signal Group Corp. 2012-02-29
NCT01351727 Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors https://ClinicalTrials.gov/show/NCT01351727 Completed University of Arizona 2014-09-30
NCT01338363 Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists https://ClinicalTrials.gov/show/NCT01338363 Completed AstraZeneca 2015-08-31
NCT04257604 A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures https://ClinicalTrials.gov/show/NCT04257604 Completed Eisai Inc. 2019-04-30
NCT04230044 A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy https://ClinicalTrials.gov/show/NCT04230044 Completed Eisai Inc. 2017-07-03
NCT04221282 ZEBinix® Retention Rate in Epilepsy in Elderly Patients https://ClinicalTrials.gov/show/NCT04221282 Recruiting Centre Hospitalier Saint Joseph Saint Luc de Lyon 2020-09-30
NCT04204863 Status Epilepticus Unicenter Population (STEP UP) Study https://ClinicalTrials.gov/show/NCT04204863 Recruiting University Hospital, Basel, Switzerland 2021-12-31
NCT04076449 Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy https://ClinicalTrials.gov/show/NCT04076449 Recruiting Beijing Tiantan Hospital 2026-12-31
NCT04061707 Subcutaneous EEG: Forecasting of Epileptic Seizures https://ClinicalTrials.gov/show/NCT04061707 Recruiting King’s College London 2021-05-15
NCT04022486 Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis https://ClinicalTrials.gov/show/NCT04022486 Completed Hospices Civils de Lyon 2018-08-01
NCT03934268 A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy https://ClinicalTrials.gov/show/NCT03934268 Recruiting Children’s Hospital of Fudan University 2022-12-31
NCT03856775 Detecting Non-convulsive Seizures in the Paediatric Intensive Care Unit https://ClinicalTrials.gov/show/NCT03856775 Recruiting McMaster University 2021-12-31
NCT03848273 Post Stroke Epileptic Seizures Risk Forecast https://ClinicalTrials.gov/show/NCT03848273 Recruiting Lviv National Medical University 2020-12-31
NCT03836924 A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older https://ClinicalTrials.gov/show/NCT03836924 Active, not recruiting Eisai Inc. 2020-02-08
NCT03796520 Validation Study of the Simplified Seizure Classification Algorithm https://ClinicalTrials.gov/show/NCT03796520 Completed Aarhus University Hospital 2019-01-31
NCT03753035 Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children https://ClinicalTrials.gov/show/NCT03753035 Recruiting Central Hospital, Nancy, France 2019-04-30
NCT03656939 A Safety Study For Prevenar 13 Among Chinese Children https://ClinicalTrials.gov/show/NCT03656939 Active, not recruiting Pfizer 2020-09-30
NCT03561168 Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years https://ClinicalTrials.gov/show/NCT03561168 Completed Baylor College of Medicine 2018-06-15
NCT03534258 Does Use of Rapid Response EEG Impact Clinical Decision Making https://ClinicalTrials.gov/show/NCT03534258 Completed Ceribell Inc. 2019-04-30
NCT03533374 Validation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With Epilepsy https://ClinicalTrials.gov/show/NCT03533374 Completed Aarhus University Hospital 2018-01-01
NCT03481764 Anthropogenetic Variability in the Group of Individuals With Febrile Seizures https://ClinicalTrials.gov/show/NCT03481764 Completed Institut za Rehabilitaciju Sokobanjska Beograd 2018-04-30
NCT03478852 Investigating Epilepsy: Screening, Evaluation and Treatment https://ClinicalTrials.gov/show/NCT03478852 Recruiting National Institutes of Health Clinical Center (CC) 2027-07-30
NCT03465189 Validation of a Seizure Monitoring System https://ClinicalTrials.gov/show/NCT03465189 Active, not recruiting St Vincent’s Hospital Melbourne 2019-03-22
NCT03419260 Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children https://ClinicalTrials.gov/show/NCT03419260 Recruiting Children’s Hospital of Philadelphia 2020-06-01
NCT01261416 Pharmacokinetics of Levetiracetam (Keppra) in Neonates https://ClinicalTrials.gov/show/NCT01261416 Completed Children’s Hospital Medical Center, Cincinnati 2010-07-31
NCT01236001 Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older https://ClinicalTrials.gov/show/NCT01236001 Completed UCB Pharma 2012-03-31
NCT01214707 Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy https://ClinicalTrials.gov/show/NCT01214707 Completed Cyberonics, Inc. 2011-10-31
NCT01123746 Utility of Laboratory Testing for Children With Seizure in Emergency Department https://ClinicalTrials.gov/show/NCT01123746 Completed Taipei Medical University WanFang Hospital 2009-12-31
NCT01123213 Characteristics Predictive of Pessary Success https://ClinicalTrials.gov/show/NCT01123213 Completed University of California, Irvine 2011-08-31
NCT01073579 Sabril Patient Registry https://ClinicalTrials.gov/show/NCT01073579 Completed Lundbeck LLC 2016-07-31
NCT01030094 A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy https://ClinicalTrials.gov/show/NCT01030094 Completed Janssen Korea, Ltd., Korea 2009-04-30
NCT00884351 Magnetoencephalography in Absence Seizures https://ClinicalTrials.gov/show/NCT00884351 Completed National Institutes of Health Clinical Center (CC) NA
NCT04426994 Hypomagnesemia Associated With Proton-Pump Inhibitor Use https://ClinicalTrials.gov/show/NCT04426994 Completed Changi General Hospital 2018-01-30
NCT04023851 Mobile Application of Seizure Diary (Brain4U) in Epilepsy Care https://ClinicalTrials.gov/show/NCT04023851 Recruiting Seoul National University Hospital 2019-12-31
NCT03860467 Epileptic Seizures in Intensive Care Units https://ClinicalTrials.gov/show/NCT03860467 Recruiting University Hospital, Basel, Switzerland 2020-10-31
NCT04259125 Evaluating the Role of Inflammation in Neonatal Epileptogenesis https://ClinicalTrials.gov/show/NCT04259125 Recruiting University of California, San Francisco 2023-05-31
NCT00771927 Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures https://ClinicalTrials.gov/show/NCT00771927 Completed UCB Pharma 2012-03-31
NCT00717483 BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes https://ClinicalTrials.gov/show/NCT00717483 Completed Baylor College of Medicine 2010-01-31
NCT00684424 Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency https://ClinicalTrials.gov/show/NCT00684424 Completed Pfizer 2009-03-31
NCT00497835 Study of Algorithm for Epilepsy Alert Device https://ClinicalTrials.gov/show/NCT00497835 Completed Biolert 2010-10-31
NCT00456391 The Utility of Performing Brain CT Scan in Non Trauma Patients at the Pediatric Emergency Unit https://ClinicalTrials.gov/show/NCT00456391 Completed HaEmek Medical Center, Israel NA
NCT00345475 UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry) https://ClinicalTrials.gov/show/NCT00345475 Completed UCB Pharma 2016-05-31
NCT00298246 Clinical and Immunological Investigations of Subtypes of Autism https://ClinicalTrials.gov/show/NCT00298246 Completed National Institutes of Health Clinical Center (CC) NA
NCT00297349 A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures https://ClinicalTrials.gov/show/NCT00297349 Completed Janssen Cilag Pharmaceutica S.A.C.I., Greece NA
NCT00297323 An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy https://ClinicalTrials.gov/show/NCT00297323 Completed Janssen Cilag Pharmaceutica S.A.C.I., Greece NA
NCT00255411 Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure https://ClinicalTrials.gov/show/NCT00255411 Completed National Institutes of Health Clinical Center (CC) NA
NCT00224952 Pathogenesis of Adverse Drug Reactions https://ClinicalTrials.gov/show/NCT00224952 Completed Children’s Mercy Hospital Kansas City 2010-03-31
NCT00179426 Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy https://ClinicalTrials.gov/show/NCT00179426 Completed Beth Israel Deaconess Medical Center NA
NCT00071305 Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings https://ClinicalTrials.gov/show/NCT00071305 Completed National Institutes of Health Clinical Center (CC) 2009-10-06
NCT00044252 Role of Hormones in Susceptibility to Seizures in Women With Epilepsy https://ClinicalTrials.gov/show/NCT00044252 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041951 Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study https://ClinicalTrials.gov/show/NCT00041951 Completed Icahn School of Medicine at Mount Sinai 2014-07-31
NCT00021866 Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy https://ClinicalTrials.gov/show/NCT00021866 Completed Emory University 2010-08-31
NCT00001666 Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy https://ClinicalTrials.gov/show/NCT00001666 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001366 Mapping the Areas of the Brain Associated With Language in Children With Epilepsy https://ClinicalTrials.gov/show/NCT00001366 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001325 Metabolic Abnormalities in Children With Epilepsy https://ClinicalTrials.gov/show/NCT00001325 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001192 Neuropsychological Evaluation of Psychiatric and Neurological Patients https://ClinicalTrials.gov/show/NCT00001192 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001149 Monitoring Patients With Uncontrolled Epilepsy https://ClinicalTrials.gov/show/NCT00001149 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001932 Serotonin Receptors in Seizure Disorders https://ClinicalTrials.gov/show/NCT00001932 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001912 Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis https://ClinicalTrials.gov/show/NCT00001912 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04337697 Neonatal Seizure Registry - Developmental Functional EValuation https://ClinicalTrials.gov/show/NCT04337697 Recruiting University of California, San Francisco 2024-02-29
NCT01774500 Biomarkers In Seizure To Predict Recurrence and Severe Outcomes https://ClinicalTrials.gov/show/NCT01774500 Completed Bistro Study Group 2014-01-31
NCT04368936 Relationship Between Polymorphisms of TRPV1 and KCC2 Gene in Children With Febrile Seizures https://ClinicalTrials.gov/show/NCT04368936 Enrolling by invitation Institut za Rehabilitaciju Sokobanjska Beograd 2019-05-15
NCT04171934 Clinical Validation of a Video-based Epilepsy Examination Service https://ClinicalTrials.gov/show/NCT04171934 Active, not recruiting Tampere University 2019-12-31
NCT03892798 Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene https://ClinicalTrials.gov/show/NCT03892798 Recruiting Children’s Hospital Medical Center, Cincinnati 2038-12-31
NCT03655366 Epidogs International Inventory of Seizure Alert Dogs https://ClinicalTrials.gov/show/NCT03655366 Completed University Hospital, Ghent 2018-07-01
NCT03492060 A Natural History Study of hnRNP-related Disorders https://ClinicalTrials.gov/show/NCT03492060 Recruiting Columbia University 2023-04-30
NCT03529045 Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. https://ClinicalTrials.gov/show/NCT03529045 Recruiting LivaNova 2026-12-31